| 05/08/2026 7:30 AM | Alamar Biosciences (2104204) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/08/2026 7:05 AM | Alamar Biosciences (2104204) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/23/2026 3:24 PM | Alamar Biosciences (2104204) Subject Illumina Innovation Fund II, L.P. (1779218) Filed by | Form SCHEDULE 13D | |
| 04/23/2026 12:57 PM | Alamar Biosciences (2104204) Subject Sands Capital Life Sciences Pulse Fund II, L.P. (1875620) Filed by | Form SCHEDULE 13D | |
| 04/22/2026 3:16 PM | Alamar Biosciences (2104204) Issuer Qiming Corporate GP VI, Ltd. (2059127) Reporting Qiming GP VIII, LLC (2129740) Reporting Qiming GP VIII-HC, LLC (2129671) Reporting Qiming Managing Directors Fund VI, L.P. (1733282) Reporting Qiming Venture Partners VI, L.P. (1733278) Reporting Qiming Venture Partners VIII Investments, LLC (2129618) Reporting Qiming Venture Partners VIII-HC, L.P. (1910025) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 11:15 PM | Alamar Biosciences (2104204) Filer | Form EFFECT | |
| 04/20/2026 7:37 PM | Alamar Biosciences (2104204) Issuer Chambers Rebecca (1823563) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 7:45 PM | Alamar Biosciences (2104204) Issuer Illumina Innovation Fund II GP, L.L.C. (1779219) Reporting Illumina Innovation Fund II, L.P. (1779218) Reporting Illumina Innovation Fund III GP, L.L.C. (2032563) Reporting Illumina Innovation Fund III, L.P. (2032562) Reporting Naclerio Nicholas (1534166) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 7:31 PM | Alamar Biosciences (2104204) Issuer Naclerio Nicholas (1534166) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 7:33 PM | Alamar Biosciences (2104204) Issuer McAnear Justin J. (1786386) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 7:33 PM | Alamar Biosciences (2104204) Issuer Luo Yuling (2126941) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ALMR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Alamar Biosciences and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/20/2026 7:34 PM | Alamar Biosciences (2104204) Issuer Chen Shiping (2126944) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 7:35 PM | Alamar Biosciences (2104204) Issuer White Timothy Ogden (2126704) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 7:37 PM | Alamar Biosciences (2104204) Issuer Witney Frank (1455312) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 3:40 PM | Alamar Biosciences (2104204) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 04/20/2026 3:02 PM | Alamar Biosciences (2104204) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/20/2026 7:39 AM | Alamar Biosciences (2104204) Filer | Form POS AM | |
| 04/17/2026 3:34 PM | Alamar Biosciences (2104204) Filer | Form 424B4 | |
| 04/16/2026 11:15 PM | Alamar Biosciences (2104204) Filer | Form EFFECT | |
| 04/16/2026 8:23 PM | Alamar Biosciences (2104204) Issuer Witney Frank (1455312) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/16/2026 8:23 PM | Alamar Biosciences (2104204) Issuer Qiming Corporate GP VI, Ltd. (2059127) Reporting Qiming GP VIII, LLC (2129740) Reporting Qiming GP VIII-HC, LLC (2129671) Reporting Qiming Managing Directors Fund VI, L.P. (1733282) Reporting Qiming Venture Partners VI, L.P. (1733278) Reporting Qiming Venture Partners VIII Investments, LLC (2129618) Reporting Qiming Venture Partners VIII-HC, L.P. (1910025) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/16/2026 8:30 PM | Alamar Biosciences (2104204) Issuer Illumina Innovation Fund II GP, L.L.C. (1779219) Reporting Illumina Innovation Fund II, L.P. (1779218) Reporting Illumina Innovation Fund III GP, L.L.C. (2032563) Reporting Illumina Innovation Fund III, L.P. (2032562) Reporting Naclerio Nicholas (1534166) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/16/2026 8:09 PM | Alamar Biosciences (2104204) Issuer Luo Yuling (2126941) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/16/2026 8:13 PM | Alamar Biosciences (2104204) Issuer Chen Shiping (2126944) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/16/2026 8:14 PM | Alamar Biosciences (2104204) Issuer White Timothy Ogden (2126704) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/16/2026 8:16 PM | Alamar Biosciences (2104204) Issuer McAnear Justin J. (1786386) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/16/2026 8:17 PM | Alamar Biosciences (2104204) Issuer Naclerio Nicholas (1534166) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/16/2026 8:19 PM | Alamar Biosciences (2104204) Issuer Chambers Rebecca (1823563) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/16/2026 8:21 PM | Alamar Biosciences (2104204) Issuer Ratcliffe Ian W (1304782) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/16/2026 7:33 PM | Alamar Biosciences (2104204) Filer | Form S-1MEF | |
| 04/16/2026 2:14 PM | Alamar Biosciences (2104204) Filer | Form CERT | |
| 04/16/2026 8:25 AM | Alamar Biosciences (2104204) Filer | Form S-1/A | |
| 04/15/2026 3:05 PM | Alamar Biosciences (2104204) Filer | Form 8-A12B | |
| 04/13/2026 5:05 AM | Alamar Biosciences (2104204) Filer | Form S-1/A | |
| 03/27/2026 3:12 PM | Alamar Biosciences (2104204) Filer | Form S-1 Registration statement under Securities Act of 1933 | |